Mood stabilisers

被引：0
|
作者：
Khoo, Jon-Paul [1 ]
机构：
[1] Toowong Specialist Clin, Brisbane, Qld, Australia
来源：
AUSTRALIAN PRESCRIBER | 2012年 / 35卷 / 05期
关键词：
anticonvulsants; antipsychotics; bipolar disorder; lithium; RANDOMIZED CONTROLLED-TRIALS; BIPOLAR-II DEPRESSION; DOUBLE-BLIND; CLINICAL-PRACTICE; ACUTE MANIA; DISORDER; METAANALYSIS; LITHIUM; MONOTHERAPY; VALPROATE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Many of the drugs used to treat bipolar disorder can be considered to stabilise specific mood phases. Based on current evidence, lithium and perhaps sodium valproate are the only drugs effective for both acute treatment and the prevention of future episodes. Quetiapine might also have true mood stabilising properties. Other anticonvulsants and antipsychotics have evidence to show that they stabilise certain mood states or illness trajectories. They may be used in acute treatment of bipolar disorder, but there is less evidence for their role in maintenance treatment to prevent recurrence.
引用
收藏
页码：164 / 168
页数：5
相关论文
共 50 条
  • [41] Mood stabilisers and atypical antipsychotics in the long-term treatment of bipolar disorder
    Altamura, A. C.
    Buoli, M.
    Paoli, R. A.
    Primavera, D.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S404 - S405
  • [42] The impact of mood stabilisers on the emotionally modulated response inhibition in euthymic bipolar patients
    Novak, T.
    Sprah, L.
    Tavcar, R.
    Dernovsek, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S421 - S422
  • [43] Audit on monitoring physical health of patients on mood stabilisers following NICE guidelines
    Soundararajan, Sathyan
    Dhandapani, Asha
    Jones, Claire
    [J]. BJPSYCH OPEN, 2021, 7 : S104 - S105
  • [44] Response to the article entitled 'Mood stabilisers and risk of stroke in bipolar disorder' Reply
    Kuo, Chian-Jue
    Chen, Pao-Huan
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2019, 214 (05) : 305 - 306
  • [45] Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review
    Van Lieshout, Ryan J.
    MacQueen, Glenda M.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2010, 196 (04) : 266 - 273
  • [46] AUDIT ON EFFECTS OF MOOD STABILISERS ON WOMEN'S HEALTH - INFORMED DECISION MAKING
    Mothi, M.
    Chambers, C.
    Shora, S.
    Jabeen, A.
    [J]. EUROPEAN PSYCHIATRY, 2013, 28
  • [47] Molecular signatures of mood stabilisers highlight the role of the transcription factor REST/NRSF
    Warburton, Alix
    Savage, Abigail L.
    Myers, Paul
    Peeney, David
    Bubb, Vivien J.
    Quinn, John P.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2015, 172 : 63 - 73
  • [48] Prevalence and correlates of non-adherence with mood stabilisers in patients with bipolar I disorder
    Mechri, A.
    Bouzgarrou, L.
    Mrad, A.
    Douki, W.
    Najjar, M. F.
    Gaha, L.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S470 - S471
  • [49] Review: Adding second generation antipsychotics to mood stabilisers reduces acute mania symptoms
    Perlis, Roy
    [J]. EVIDENCE-BASED MENTAL HEALTH, 2007, 10 (04)
  • [50] Treat bipolar depression with atypical antipsychotics and mood stabilisers; new therapies require further study
    Simon Fung
    [J]. Drugs & Therapy Perspectives, 2024, 40 : 109 - 114
12345